Evidence map›Paper›PMID 25904908›Full record

ArticleFrontiers in microbiology2015

Identification of novel esterase-active enzymes from hot environments by use of the host bacterium Thermus thermophilus.

Benedikt Leis, Angel Angelov, Markus Mientus, Haijuan Li, Vu T T Pham, Benjamin Lauinger, Patrick Bongen, Jörg Pietruszka, Luís G Gonçalves, Helena Santos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Benedikt LeisDepartment of Microbiology, Technische Universität München Freising, Germany.
Angel AngelovDepartment of Microbiology, Technische Universität München Freising, Germany.
Markus MientusDepartment of Microbiology, Technische Universität München Freising, Germany.
Haijuan LiDepartment of Microbiology, Technische Universität München Freising, Germany.
Vu T T PhamDepartment of Microbiology, Technische Universität München Freising, Germany.
Benjamin LauingerResearch Center Juelich, Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf Juelich, Germany.
Patrick BongenResearch Center Juelich, Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf Juelich, Germany.
Jörg PietruszkaResearch Center Juelich, Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf Juelich, Germany.
Luís G GonçalvesInstituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa Oeiras, Portugal.
Helena SantosInstituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa Oeiras, Portugal.
Wolfgang LieblDepartment of Microbiology, Technische Universität München Freising, Germany.
Technical University of Munich · DEUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional metagenomic screening strategies, which are independent of known sequence information, can lead to the identification of truly novel genes and enzymes. Since E. coli has been used exhaustively for this purpose as a host, it is important to establish alternative expression hosts and to use them for functional metagenomic screening for new enzymes. In this study we show that Thermus thermophilus HB27 is an excellent screening host and can be used as an alternative provider of truly novel biocatalysts. In a previous study we constructed mutant strain BL03 with multiple markerless deletions in genes for major extra- and intracellular lipolytic activities. This esterase-diminished strain was no longer able to grow on defined minimal medium supplemented with tributyrin as the sole carbon source and could be used as a host to screen for metagenomic DNA fragments that could complement growth on tributyrin. Several thousand single fosmid clones from thermophilic metagenomic libraries from heated compost and hot spring water samples were subjected to a comparative screening for esterase activity in both T. thermophilus strain BL03 and E. coli EPI300. We scored a greater number of active esterase clones in the thermophilic bacterium than in the mesophilic E. coli. From several thousand functionally screened clones only two thermostable α/β-fold hydrolase enzymes with high amino acid sequence similarity to already characterized enzymes were identifiable in E. coli. In contrast, five further fosmids were found that conferred lipolytic activities in T. thermophilus only. Four open reading frames (ORFs) were found which did not share significant similarity to known esterase enzymes but contained the conserved GXSXG motif regularly found in lipolytic enzymes. Two of the genes were expressed in both hosts and the novel thermophilic esterases, which based on their primary structures could not be assigned to known esterase or lipase families, were purified and preliminarily characterized. Our work underscores the benefit of using additional screening hosts other than E. coli for the identification of novel biocatalysts with industrial relevance.

Indexed as

comparative screeningfunctional metagenomicsnovel metagenomic esterasesnovel screening hostThermus thermophiles

Identifiers

PMID25904908
PMCPMC4389547
OpenAlexW1994237264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.